TP53 and cancer: The KEGG pathway enrichment results revealed that the putative targets were significantly enriched in hepatitis B and viral carcinogenesis, and the cAMP signaling pathway, PI3K-Akt signaling route, MAPK signaling pathway, estrogen signaling pathway, p53 signaling pathway, and cell cycle signaling pathway were all found to be enriched in cancer pathways.